Catalent Names Thomas Castellano CFO
07:43 AM EDT, 05/11/2021 (MT Newswires) -- Catalent (CTLT) has named Thomas Castellano as the pharmaceutical company's chief financial officer starting June 1.
Castellano will replace Wetteny Joseph, who will be leaving the company to become the CFO of animal health company Zoetis Inc. (ZTS).
Castellano, who is currently Catalent's global vice president of operational finance, joined the company in 2008 as director for financial planning & analysis, and has held successively senior positions since then. Prior to Catalent, Castellano worked with the capital markets finance group at Lehman Brothers.
Shares of Catalent are down nearly 3% in premarket trading.
Price: 102.00, Change: -2.80, Percent Change: -2.67